Eyenovia Statistics
Total Valuation
Eyenovia has a market cap or net worth of $42.03 million. The enterprise value is $56.57 million.
Important Dates
The next confirmed earnings date is Tuesday, November 12, 2024, after market close.
Earnings Date | Nov 12, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Eyenovia has 86.38 million shares outstanding. The number of shares has increased by 28.63% in one year.
Current Share Class | 86.38M |
Shares Outstanding | 86.38M |
Shares Change (YoY) | +28.63% |
Shares Change (QoQ) | +13.98% |
Owned by Insiders (%) | 13.50% |
Owned by Institutions (%) | 7.41% |
Float | 68.66M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | 6.89 |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 1,801.19 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.46
Current Ratio | 0.46 |
Quick Ratio | 0.17 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -13.25 |
Financial Efficiency
Return on equity (ROE) is -914.66% and return on invested capital (ROIC) is -112.46%.
Return on Equity (ROE) | -914.66% |
Return on Assets (ROA) | -92.94% |
Return on Capital (ROIC) | -112.46% |
Revenue Per Employee | $551 |
Profits Per Employee | -$654,064 |
Employee Count | 57 |
Asset Turnover | 0.00 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -62.71% in the last 52 weeks. The beta is 1.75, so Eyenovia's price volatility has been higher than the market average.
Beta (5Y) | 1.75 |
52-Week Price Change | -62.71% |
50-Day Moving Average | 0.51 |
200-Day Moving Average | 0.93 |
Relative Strength Index (RSI) | 44.01 |
Average Volume (20 Days) | 858,035 |
Short Selling Information
The latest short interest is 2.29 million, so 2.65% of the outstanding shares have been sold short.
Short Interest | 2.29M |
Short Previous Month | 3.29M |
Short % of Shares Out | 2.65% |
Short % of Float | 3.33% |
Short Ratio (days to cover) | 2.97 |
Income Statement
In the last 12 months, Eyenovia had revenue of $31,405 and -$37.28 million in losses. Loss per share was -$0.79.
Revenue | 31,405 |
Gross Profit | -5.53M |
Operating Income | -35.94M |
Pretax Income | -32.44M |
Net Income | -37.28M |
EBITDA | -34.80M |
EBIT | -35.94M |
Loss Per Share | -$0.79 |
Full Income Statement Balance Sheet
The company has $2.30 million in cash and $15.66 million in debt, giving a net cash position of -$13.36 million or -$0.15 per share.
Cash & Cash Equivalents | 2.30M |
Total Debt | 15.66M |
Net Cash | -13.36M |
Net Cash Per Share | -$0.15 |
Equity (Book Value) | -2.37M |
Book Value Per Share | -0.04 |
Working Capital | -8.56M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$30.23 million and capital expenditures -$885,248, giving a free cash flow of -$31.11 million.
Operating Cash Flow | -30.23M |
Capital Expenditures | -885,248 |
Free Cash Flow | -31.11M |
FCF Per Share | -$0.36 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | -114,446.45% |
Pretax Margin | -118,712.53% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -341,869.79% |
Dividends & Yields
Eyenovia does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -28.63% |
Shareholder Yield | -28.63% |
Earnings Yield | -84.58% |
FCF Yield | -70.59% |
Analyst Forecast
The average price target for Eyenovia is $12.00, which is 2,366.09% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $12.00 |
Price Target Difference | 2,366.09% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | 681.35% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Eyenovia has an Altman Z-Score of -17.33 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -17.33 |
Piotroski F-Score | 2 |